These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21404974)

  • 1. Injection drug users can be effectively treated for hepatitis C.
    Stancliff S
    Am Fam Physician; 2011 Mar; 83(6):647; author reply 648. PubMed ID: 21404974
    [No Abstract]   [Full Text] [Related]  

  • 2. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
    Gazdag G; Horvath G; Szabo O; Ungvari GS
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
    Dore GJ
    Hepatology; 2007 Jan; 45(1):3-5. PubMed ID: 17187427
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C treatment for injection drug users: a review of the available evidence.
    Hellard M; Sacks-Davis R; Gold J
    Clin Infect Dis; 2009 Aug; 49(4):561-73. PubMed ID: 19589081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prisons, prisoners, and hepatitis C.
    Ferguson L; Batey R
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acute C hepatitis in intravenous drug users.
    Bargiacchi O; Audagnotto S; Garazzino S; De Rosa FG
    J Hepatol; 2005 Jul; 43(1):186-7. PubMed ID: 15893846
    [No Abstract]   [Full Text] [Related]  

  • 7. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
    Hagan H; Latka MH; Campbell JV; Golub ET; Garfein RS; Thomas DA; Kapadia F; Strathdee SA;
    Clin Infect Dis; 2006 Mar; 42(5):669-72. PubMed ID: 16447112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C in active drug users.
    Davis GL; Rodrigue JR
    N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis C virus reinfection after an intravenous drug injection].
    Payen JL; Izopet J; Barange K; Puel J; Selves J; Pascal JP
    Gastroenterol Clin Biol; 1998 Apr; 22(4):469-70. PubMed ID: 9762279
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C infection and injection drug use: the role of hepatologists in evolving treatment efforts.
    Kresina TF; Seeff LB; Francis H
    Hepatology; 2004 Sep; 40(3):516-9. PubMed ID: 15349886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 12. [New guidelines for investigation and treatment of hepatitis C].
    Dalgard O
    Tidsskr Nor Laegeforen; 2011 Jan; 131(1):15. PubMed ID: 21233879
    [No Abstract]   [Full Text] [Related]  

  • 13. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
    Dore GJ; Thomas DL
    Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus serology in parenteral drug users with chronic liver disease.
    Novick DM; Reagan KJ; Croxson TS; Gelb AM; Stenger RJ; Kreek MJ
    Addiction; 1997 Feb; 92(2):167-71. PubMed ID: 9158228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is hepatitis C important for drug addicts?].
    Aavitsland P
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1623. PubMed ID: 19721475
    [No Abstract]   [Full Text] [Related]  

  • 16. [Membranous nephropathy and hepatitis C virus infection].
    Egea JJ; Rivera F; Arenas MD; Olivares J
    Nefrologia; 2001; 21(4):411-2. PubMed ID: 11816520
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hepatitis C in injection drug users.
    Scott LD
    Am J Gastroenterol; 2005 Jan; 100(1):5-7. PubMed ID: 15654772
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.
    Grebely J; Bruneau J; Bruggmann P; Harris M; Hickman M; Rhodes T; Treloar C; ;
    Int J Drug Policy; 2017 Sep; 47():26-33. PubMed ID: 28888558
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and treatment of hepatitis C in injection drug users.
    Edlin BR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S210-9. PubMed ID: 12407596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating intravenous drug users with hepatitis C infection: an opportunity in some settings.
    Chong VH; Jamaludin AZ; Jacob AP; Jalihal A
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1121. PubMed ID: 16957520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.